deltatrials
Active Not Recruiting NA INTERVENTIONAL 10-arm NCT02735252

PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer

Precision Oncology and Molecular Targeting in Advanced Genitourinary Cancers: Identifying Predictive Markers of Response (The PROMOTE Study)

Sponsor: Prostate Cancer Foundation

Conditions Advanced Renal Cell Carcinoma Advanced Urothelial Carcinoma Genitourinary Cancer Prostate Cancer
Interventions StrataNGS Systemic therapy
Updated 19 times since 2017 Last updated: Nov 7, 2025 Started: May 25, 2016 Primary completion: Mar 31, 2027 Completion: Mar 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02735252, this NA trial focuses on Advanced Renal Cell Carcinoma and Advanced Urothelial Carcinoma and remains ongoing. Sponsored by Prostate Cancer Foundation, it has been updated 19 times since 2016, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Aug 2017 · 7 months · monthly snapshot~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Aug 2019 · 14 months · monthly snapshot~Aug 2019 – ~Sep 2019 · 31 days · monthly snapshot~Sep 2019 – ~Feb 2020 · 5 months · monthly snapshot~Feb 2020 – ~Apr 2020 · 2 months · monthly snapshot~Apr 2020 – ~Oct 2020 · 6 months · monthly snapshot~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Jun 2021 · 5 months · monthly snapshot~Jun 2021 – ~Jul 2022 · 13 months · monthly snapshot~Jul 2022 – ~Sep 2022 · 2 months · monthly snapshot~Sep 2022 – ~Aug 2023 · 11 months · monthly snapshot~Aug 2023 – ~Jul 2024 · 11 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jan 2025 · 4 months · monthly snapshot~Jan 2025 – ~Dec 2025 · 11 months · monthly snapshot~Dec 2025 – present · 7 months · monthly snapshot

Change History

19 versions recorded

  1. Dec 2025 — Present [monthly]

    Active Not Recruiting NA

  2. Jan 2025 — Dec 2025 [monthly]

    Active Not Recruiting NA

  3. Sep 2024 — Jan 2025 [monthly]

    Active Not Recruiting NA

  4. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting NA

  5. Aug 2023 — Jul 2024 [monthly]

    Active Not Recruiting NA

▶ Show 14 earlier versions

  1. Sep 2022 — Aug 2023 [monthly]

    Active Not Recruiting NA

    Status: Recruiting → Active Not Recruiting

  2. Jul 2022 — Sep 2022 [monthly]

    Recruiting NA

  3. Jun 2021 — Jul 2022 [monthly]

    Recruiting NA

  4. Jan 2021 — Jun 2021 [monthly]

    Recruiting NA

  5. Oct 2020 — Jan 2021 [monthly]

    Recruiting NA

  6. Apr 2020 — Oct 2020 [monthly]

    Recruiting NA

  7. Feb 2020 — Apr 2020 [monthly]

    Recruiting NA

  8. Sep 2019 — Feb 2020 [monthly]

    Recruiting NA

  9. Aug 2019 — Sep 2019 [monthly]

    Recruiting NA

    Phase: None → NA

  10. Jun 2018 — Aug 2019 [monthly]

    Recruiting

  11. May 2018 — Jun 2018 [monthly]

    Recruiting

  12. Apr 2018 — May 2018 [monthly]

    Recruiting

    Phase: NA → None

  13. Aug 2017 — Apr 2018 [monthly]

    Recruiting NA

  14. Jan 2017 — Aug 2017 [monthly]

    Recruiting NA

    First recorded

May 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Prostate Cancer Foundation
  • Strata Oncology
  • University of California, San Francisco
Data source: University of California, San Francisco

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations